Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2000
10/19/2000CA2365929A1 Novel method for identifying antibacterial compounds
10/19/2000CA2365918A1 49 human secreted proteins
10/19/2000CA2365917A1 Bone morphogenic proteins
10/19/2000CA2365915A1 Recombinant toxin a/toxin b vaccine against clostridium difficile
10/19/2000CA2365914A1 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
10/19/2000CA2365913A1 Tumor necrosis factor receptor homologs and nucleic acids encoding the same
10/19/2000CA2365912A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/19/2000CA2365910A1 Human proteins and polynucleotides encoding them
10/19/2000CA2365908A1 Reagents and methods for identifying and modulating expression of genes regulated by p21
10/19/2000CA2365905A1 48 human secreted proteins
10/19/2000CA2365623A1 Tyrosine kinase substrate (tks) proteins
10/19/2000CA2365522A1 48 human secreted proteins
10/19/2000CA2364690A1 Novel transduction molecules and methods for using same
10/19/2000CA2364572A1 Pcr-based cloning method
10/19/2000CA2364541A1 Genes associated with diseases of the kidney
10/19/2000CA2364536A1 Fragments of virus protein 2 or 3 of polyoma virus, as vehicules for active substances
10/19/2000CA2360318A1 A second mammalian tankyrase
10/18/2000EP1045023A1 Serum free medium
10/18/2000EP1044987A2 Gapped 2'-modified oligonucleotides
10/18/2000EP1044605A1 Gene mutant animals
10/18/2000EP1044279A1 Plants with modified growth
10/18/2000EP1044274A2 Adenoviral vectors with modified capsid proteins
10/18/2000EP1044273A2 COMPOSITIONS DERIVED FROM $i(MYCOBACTERIUM VACCAE) AND METHODS FOR THEIR USE
10/18/2000EP1044272A2 Method for controlling the division and/or elongation of eukariotic cells
10/18/2000EP1044271A1 Il-1 delta dna and polypeptides
10/18/2000EP1044270A2 Apoptosis inducing molecule ii
10/18/2000EP1044269A1 Human vps35/mem3-related protein
10/18/2000EP1044268A1 Novel sequence variants of the human beta2-adrenergic receptor gene and use thereof
10/18/2000EP1044267A2 Novel nucleic acid and polypeptide with homology to the tnf-receptors
10/18/2000EP1044266A2 Human signal peptide-containing proteins
10/18/2000EP1044265A1 Dna encoding a gaba br2 polypeptide and uses thereof
10/18/2000EP1044263A2 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS
10/18/2000EP1044220A1 Secreted proteins and polynucleotides encoding them
10/18/2000EP1044219A1 DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEIN, nNR5
10/18/2000EP1044218A1 Nucleic acids encoding transferrin receptor-like proteins and products related thereto
10/18/2000EP1044217A2 Sag: sensitive to apoptosis gene
10/18/2000EP1044216A1 DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEINS, nNR7 AND nNR7-1
10/18/2000EP1044214A1 Method for binding albumin and means to be used in the method
10/18/2000EP1044212A1 Human fk506 binding proteins
10/18/2000EP1044211A1 36 human secreted proteins
10/18/2000EP1044210A1 Human dendriac and brainiac-3
10/18/2000EP1044194A1 Receptor with an affinity for compounds of the oxazoline class
10/18/2000EP1044020A2 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products
10/18/2000EP1044019A1 Methods and compositions for desensitisation
10/18/2000EP1044015A1 Formulations for amylin agonist peptides
10/18/2000EP1043959A1 Interactive dental restorative network
10/18/2000EP0828507A4 Method for treatment of pain
10/18/2000EP0827513A4 Methods of treatment and diagnostic visualisation, particularly in cancer
10/18/2000EP0577666B1 Polypeptides from mycobacterium paratuberculosis
10/18/2000EP0467932B1 Urokinase-type plasminogen activator receptor
10/18/2000CN1270637A Isolation of a novel senescence-factor gene, P23
10/18/2000CN1270635A Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these protein
10/18/2000CN1270633A Human chloride ion channel ZSIG44
10/18/2000CN1270632A APPIL-a novel protein with growth effects
10/18/2000CN1270497A Toxin genes from the bacteria i (xenorhabdus nematophilus) and i (photorhabdus luminescens)
10/18/2000CN1270222A Human coenzyme I subunit isomer protein and its coding sequence
10/18/2000CN1270221A Human adenosine triphosphatase subunit protein and its coding sequence
10/18/2000CN1270220A Human protein related to VB12 and its coding sequence
10/18/2000CN1270061A 弯曲菌疫苗 Campylobacter vaccine
10/18/2000CN1057535C Process for producing hydrophobic polypeptides proteins or peptides
10/18/2000CN1057534C Erythropoietin analogs
10/18/2000CN1057533C Method for producing clostridium perfringers vaccines
10/18/2000CN1057532C Process for purifying hepatitis B viral surface antigen comprising PRES2 peptide
10/17/2000US6133507 Specific nucleotide sequence which codes for a chitin binding protein of rhizomes of urtica dioica; for transgenic plants with insecticidal properties in leaves
10/17/2000US6133506 Keto-acyl-(ACP) reductase promoter from cuphea lanceolata
10/17/2000US6133505 Phytopathogenic geminivirus resistant transgenic plants and seeds and methods for obtaining same by introduction of mutated C1 gene
10/17/2000US6133502 Monocyte chemoattractant protein and its receptor transgenic animal
10/17/2000US6133444 Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
10/17/2000US6133437 Antisense nucleic acid which is complementary to specific human and mouse nucleotide sequences and suppresses the biological activity of inhibitor of apoptosis in vitro; anticarcinogenic agents
10/17/2000US6133434 Isolated nucleic acid which codes for a mammalian p2x sub 7 receptor having a defined amino acid sequence; for antiarthritic agents and therapy for respiratory system and nervous system disorders
10/17/2000US6133433 Nucleotide sequence; probes used for diagnosis; recombinant production of proteins; vaccines
10/17/2000US6133428 Antibody which binds to an epitope of a specific amino acid sequence
10/17/2000US6133425 Tetramer free, cross linked, polymerized hemoglobin from human blood; has methemoglobin reductase activity from 1.0 to 2.0 units
10/17/2000US6133424 ppRB110 - nuclear phosphoprotein-the retinoblastoma susceptibility gene product
10/17/2000US6133423 Don-1 gene and polypeptides and uses therefor
10/17/2000US6133422 Purified protein having defined amino acid sequence; anticoagulants
10/17/2000US6133421 Polypeptides and polypeptide subunits of a stereospecific nitrile hydratase enzyme
10/17/2000US6133420 GPR14 polypeptides
10/17/2000US6133419 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
10/17/2000US6133418 Synthetic peptide inhibitors of HIV transmission
10/17/2000US6133416 Inhibition of cell growth by an anti-proliferative factor
10/17/2000US6133244 Method for immunization against hepatitis B
10/17/2000US6133235 Glucagon-like insulinotropic peptides compositions and methods
10/17/2000US6133232 Protein or fragment having neurotrophic, growth or differentiation factor activity in xenopus embryos
10/17/2000US6133049 Methods, agents and kits for detection of organophosphorus compounds
10/17/2000US6133029 Replication defective viral vectors for infecting human cells
10/17/2000US6133028 For gene therapy
10/17/2000US6133025 Nucleic acid for episomal replication in mammalian cells; includes a cis-acting origin of replication sequence and the nuclear antigen 1 sequence linked to a promoter; for gene therapy
10/17/2000US6133023 Expression vector including a promoter region controlled by environmental factors such as ph, growth temperature, oxygen content, and others and at least one restriction site; for increased gene expression/production of vaccines
10/17/2000US6133017 Attenuated strain of Leishmania
10/17/2000US6133015 HHV-8+ lymphoma cell line which is HIV-, CMV-, EBV-, and which produces large amounts of uncontaminated HHV-8 virus
10/17/2000US6133011 Chimeric proteins having fibrinolytic and thrombin-inhibiting properties
10/17/2000US6133010 Chlamysin B antibacterial protein, a protein gene for and an expression system for same
10/17/2000US6132992 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
10/17/2000US6132991 Human interleukin-3 (IL-3) variant fusion proteins
10/17/2000US6132990 Recombinant methods for production of serine protease inhibitors and DNA sequences useful for same
10/17/2000US6132989 Methods and compositions for enhanced stability of non-adenoviral DNA
10/17/2000US6132988 Nucleotide sequence coding a nervous system protein; for diagnosis of nerve degredation; for detection of modulators of activin activity
10/17/2000US6132987 Polypeptide associated with macrophages; for diagnosis and treatment of inflammation, arthritis and atherosclerosis
10/17/2000US6132981 Screening for human incubation with radioactivity; scanning erythrocytes for transferrin receptors, and comparing to control cell that have not been incubated with radoactivity
1 ... 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 ... 2916